These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14162627)

  • 1. [ON RAYNAUD'S DISEASE IN CHILDREN].
    RESHETNIKOVA AD
    Pediatriia; 1963 Dec; 42():27-30. PubMed ID: 14162627
    [No Abstract]   [Full Text] [Related]  

  • 2. [Capilloroscopy of nail folds in Raynaud's syndrome during Hypacom treatment].
    Bendkowski W; Bogdanowski T
    Pol Tyg Lek; 1978 Oct; 33(41):1619-20. PubMed ID: 704471
    [No Abstract]   [Full Text] [Related]  

  • 3. RAYNAUD'S PHENOMENON.
    WADE G
    Practitioner; 1965 Feb; 194():226-33. PubMed ID: 14259706
    [No Abstract]   [Full Text] [Related]  

  • 4. [PERIPHERAL VASODILATOR ACTION OF MYDETON].
    SOOS S
    Orv Hetil; 1964 Jul; 105():1369-72. PubMed ID: 14181919
    [No Abstract]   [Full Text] [Related]  

  • 5. [Methylphenidate and secondary Raynaud's phenomenon].
    Iglesias Otero M; Portela Romero M; Bugarín González R; Ventura Victoria MA
    Semergen; 2013 Sep; 39(6):330-4. PubMed ID: 24034762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of industrial Raynaud's phenomenon by physiotherapy. I.
    STANLEY JA
    Physiotherapy; 1953 Jun; 39(6):134-42; cont. PubMed ID: 13073458
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of industrial Raynaud's phenomenon by physiotherapy. II.
    STANLEY JA
    Physiotherapy; 1953 Jul; 39(7):161-8; contd. PubMed ID: 13073463
    [No Abstract]   [Full Text] [Related]  

  • 8. VASCULAR CONSTRICTION AS A PATHOGENIC MECHANISM.
    REID JD
    N Z Med J; 1963 Jul; 62():303-10. PubMed ID: 14045688
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of Raynaud's phenomenon.
    García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R
    Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ON THE PATHOGENESIS AND THERAPY OF RAYNAUD'S DISEASE].
    BEKHTEREVA NP; GRIGORIVICH KA; ZONTOV VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1963; 63():641-8. PubMed ID: 14063622
    [No Abstract]   [Full Text] [Related]  

  • 11. [EVALUATION OF ANESTHETIC BLOCKING OF THE STELLATE GANGLION IN RAYNAUD'S PHENOMENON BY MEANS OF CLEARANCE OF RADIOACTIVE SODIUM].
    VALDES EF
    Rev Can Biol; 1964 Dec; 23():447-50. PubMed ID: 14257889
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical significance of Raynaud's syndrome.
    Porter JM; Bardana EJ; Baur GM; Wesche DH; Andrasch RH; Rösch J
    Surgery; 1976 Dec; 80(6):756-64. PubMed ID: 1006524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sarpogrelate hydrochloride for Raynaud's phenomenon of patients with collagen diseases].
    Kumagai S; Morinobu A; Ozaki S; Nakao K; Ishida H
    Ryumachi; 1998 Jun; 38(3):504-10. PubMed ID: 9721558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raynaud's phenomenon.
    O'connor CM
    J Vasc Nurs; 2001 Sep; 19(3):87-92; quiz 93-4. PubMed ID: 11533581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R; Shariat K; von Wilmowsky H; Böhm M
    Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of biofeedback training in treatment of Raynaud's disease and phenomenon.
    Yocum DE; Hodes R; Sundstrom WR; Cleeland CS
    J Rheumatol; 1985 Feb; 12(1):90-3. PubMed ID: 3981523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverting incipient gangrene in Raynaud's disease.
    DEWAR RK
    Can Med Assoc J; 1955 Jun; 72(11):848-50. PubMed ID: 14364461
    [No Abstract]   [Full Text] [Related]  

  • 18. [Raynaud's phenomenon in systemic rheumatic diseases of the connective tissue].
    Maksimović B
    Reumatizam; 1983; 30(1-2):18-20. PubMed ID: 6867506
    [No Abstract]   [Full Text] [Related]  

  • 19. [The influence of isosorbide mononitrate on skin blood flow in patients with Raynaud's syndrome].
    Gross R; Galus K; Zajac S; Jedrasik M
    Wiad Lek; 2002; 55(1-2):29-34. PubMed ID: 12043312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Local administration of cerebrolysin in Raynaud's disease in a 2-year-old child].
    Osipenko TN; Skvortsov IA; Korshunov SV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(8):100-3. PubMed ID: 1661499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.